Log In
Print
BCIQ
Print
Print this Print this
 

GLPG1205

  Manage Alerts
Collapse Summary General Information
Company Galapagos N.V.
DescriptionG protein-coupled receptor 84 (GPR84) inhibitor
Molecular Target G protein-coupled receptor 84 (GPR84)
Mechanism of ActionG protein-coupled receptor 84 (GPR84) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat ulcerative colitis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today